Why the study?
Does home blood pressure monitoring alone reliably track treatment-induced changes in blood pressure and organ damage compared to combined clinic and ambulatory measurements in patients on antihypertensive therapy?
Does home blood pressure monitoring alone reliably track treatment-induced changes in blood pressure and organ damage compared to combined clinic and ambulatory measurements in patients on antihypertensive therapy?
Home blood pressure monitoring alone may be sufficient for tracking the efficacy of antihypertensive therapy and its impact on target organ damage, without the need for combined clinic and ambulatory measurements.
Supports HBP-only monitoring for treated hypertension; confirms RCT equivalence to combined clinic-ABP for tracking effects and organ damage.
These data suggest that HBP monitoring alone is as reliable as combined clinic and ABP measurements in monitoring the effects of antihypertensive drug treatment on BP and preclinical target organ damage.
No takes yet. Share an insight, caveat, or question.
Stergiou et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: